Home > Insider Trading > Filing (0001144204-16-104305)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1429386	Phaserx Inc.	PZRX	Pharmaceutical Preparations (2834)	204690620

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673244	J Richard Ulevitch	C/O 5Am Partners Ii Llc 200 Sand Hill Road, Suite 110 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-05-23	125,829	$0.01	1,117,413	No	4	S	Indirect	By 5AM Ventures II, LP
Common Stock	Disposition	2016-05-23	312,647	$0.01	804,766	No	4	S	Indirect	By 5AM Ventures II, LP
Common Stock	Acquisiton	2016-05-23	96,204	$5.00	900,970	No	4	P	Indirect	By 5AM Ventures II, LP
Common Stock	Disposition	2016-05-23	4,965	$0.01	44,092	No	4	S	Indirect	By 5AM Co-Investors II, LP
Common Stock	Disposition	2016-05-23	12,336	$0.01	31,756	No	4	S	Indirect	By 5AM Co-Investors II, LP
Common Stock	Acquisiton	2016-05-23	3,796	$5.00	35,552	No	4	P	Indirect	By 5AM Co-Investors II, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By 5AM Ventures II, LP
No	4	S	Indirect	By 5AM Ventures II, LP
No	4	P	Indirect	By 5AM Ventures II, LP
No	4	S	Indirect	By 5AM Co-Investors II, LP
No	4	S	Indirect	By 5AM Co-Investors II, LP
No	4	P	Indirect	By 5AM Co-Investors II, LP

Footnotes

5AM Partners II LLC is the general partner of each of 5AM Ventures II, LP and 5AM Co-Investors II, LP ("5AM Ventures"). Andrew J. Schwab, John Diekman and Scott M. Rocklage are the managing members of 5AM Partners II LLC and are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own shares held by 5AM Ventures. Dr. Ulevitch is a member of and owns an interest in 5AM Partners II LLC.
Accordingly, Mr. Schwab, Dr. Diekman, Mr. Rocklage and Dr. Ulevitch may be deemed to beneficially own the securities held by 5AM Ventures. Mr. Schwab, Dr. Diekman, Mr. Rocklage and Dr. Ulevitch each disclaims beneficial ownership of these securities and this disclosure shall not be deemed an admission that Mr. Schwab, Dr. Diekman, Mr. Rocklage and Dr. Ulevitch is the beneficial owner of such securities for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or any other purpose.